Regulatory PathRegulatory requirements compared

Active substance

Dextrose

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
10% DEXTROSE W/V intravenous infusion10 %Intravenous infusion · Intravenous use1 BagSAR 6.50Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
10% Dextrose intravenous infusion10 %Solution for injection · Intravenous use1 BottleSAR 6.50Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
20%W/V DEXTROSE injection, USP20 %Solution for injection · Intravenous use1 BottleSAR 0.80Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
40% w/v DEXTROSE Injection USP40 %Solution for injection · Intravenous use1 AmpouleSAR 2.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
5 % w/v DEXTROSE Injection 500 ml5 %Solution for infusion · Intravenous use20 BottleSAR 162.00Generic · PrescriptionAL RAZI PHARMA INDUSTRIESValid
5%W/V DEXTROSE INJECTION 250ML5 %Solution for injection · Intravenous use40 BottleSAR 232.00Generic · PrescriptionAL RAZI PHARMA INDUSTRIESValid
50% w/v DEXTROSE intravenous infusion50 %Intravenous infusion · Intravenous use1 BottleSAR 5.50Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
50%W/V DESTROSE intravenous infusion50 %Intravenous infusion · Intravenous use1 BagSAR 12.70Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 10% I.V.INFUSION10 %Solution for injection · Intravenous use1 BottleSAR 3.40Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 10% I.V.INFUSION10 %Solution for injection · Intravenous use1 BagSAR 5.40Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 10% I.V.INFUSION10 %Solution for injection · Intravenous use1 BagSAR 9.25Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 10% SOLUTION FOR INJ10 %Solution for injection · Intravenous use1 BagSAR 4.30Generic · PrescriptionKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
DEXTROSE 20% INJ20 %Solution for injection · Intravenous use1 BottleSAR 0.80Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 20% INJ20 %Solution for injection · Intravenous use1 BottleSAR 1.35Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 20% W-V INFUSION20 %Solution for injection · Intravenous use1 BottleSAR 8.30Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 20% W-V INFUSION20 %Solution for injection · Intravenous use1 BagSAR 9.95Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 25% INJ25 %Solution for injection · Intravenous use1 BottleSAR 0.85Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 25% INJ25 %Solution for injection · Intravenous use1 BottleSAR 2.10Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 25% INJ25 %Solution for injection · Intravenous use1 BottleSAR 8.05Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 25% INJ25 %Solution for injection · Intravenous use1 BottleSAR 0.95Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 25% INJ25 %Solution for injection · Intravenous use1 BagSAR 11.50Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 40% INFUSION40 %Solution for injection · Intravenous use1 BagSAR 9.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 40% INFUSION40 %Solution for injection · Intravenous use1 BottleSAR 1.05Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 40% INFUSION40 %Solution for injection · Intravenous use1 BottleSAR 1.10Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE 40% INFUSION40 %Solution for injection · Intravenous use1 BottleSAR 10.20Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid

112 more — full table

Indications — CHI Daman Drug Formulary

ANESTHESIA-SUPPORTIVE AGENTS/ FLUID RESUSCITATION (UNCONTROLLED BLEEDING); DIABETIC KETOACIDOSIS; FLUIDS AND VOLUME EXPANDERS-HYPOGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
DEXTROSE 10% IN PLASTIC CONTAINER10GM/100MLinjectable · injectionBAXTER HLTHCAREPrescription25 Jan 1971
DEXTROSE 5% IN PLASTIC CONTAINER50MG/MLinjectable · injectionOTSUKA ICU MEDCLPrescription12 Feb 1971
DEXTROSE 5% IN PLASTIC CONTAINER5GM/100ML; 50MG/MLinjectable · injectionBAXTER HLTHCAREPrescription4 Mar 1971
DEXTROSE 5% IN PLASTIC CONTAINER5GM/100ML; 50MG/MLinjectable · injectionB BRAUNPrescription21 Dec 1973
DEXTROSE 10% IN PLASTIC CONTAINER10GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription28 Aug 1979
DEXTROSE 70% IN PLASTIC CONTAINER70GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription23 Mar 1982
DEXTROSE 40% IN PLASTIC CONTAINER40GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription23 Mar 1982
DEXTROSE 50% IN PLASTIC CONTAINER50GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription23 Mar 1982
DEXTROSE 20% IN PLASTIC CONTAINER20GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription23 Mar 1982
DEXTROSE 30% IN PLASTIC CONTAINER30GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription26 Jan 1985
DEXTROSE 5% IN PLASTIC CONTAINER5GM/100MLinjectable · injectionHOSPIRAPrescription15 Jul 1985
DEXTROSE 5% IN PLASTIC CONTAINER5GM/100MLinjectable · injectionHOSPIRAPrescription17 Sep 1985
DEXTROSE 50%500MG/MLinjectable · injectionHOSPIRAPrescription3 Jun 1986
DEXTROSE 25%250MG/MLinjectable · injectionHOSPIRAPrescription3 Jun 1986
DEXTROSE 5% IN PLASTIC CONTAINER5GM/100MLinjectable · injectionB BRAUNPrescription2 Feb 1988
DEXTROSE 10% IN PLASTIC CONTAINER10GM/100MLinjectable · injectionB BRAUNPrescription2 Feb 1988
DEXTROSE 70% IN PLASTIC CONTAINER70GM/100MLinjectable · injectionB BRAUNPrescription2 Feb 1988
DEXTROSE 70% IN PLASTIC CONTAINER70GM/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription26 Dec 1989
DEXTROSE 50% IN PLASTIC CONTAINER50GM/100MLinjectable · injectionBAXTER HLTHCAREPrescription2 Jul 1991
DEXTROSE 70% IN PLASTIC CONTAINER70GM/100MLinjectable · injectionBAXTER HLTHCAREPrescription2 Jul 1991
DEXTROSE 5% IN PLASTIC CONTAINER5GM/100ML; 50MG/MLinjectable · injectionBAXTER HLTHCAREPrescription7 Dec 1992
DEXTROSE 5% IN PLASTIC CONTAINER50MG/MLinjectable · injectionFRESENIUS KABI USAPrescription21 Oct 2016
DEXTROSE 10% IN PLASTIC CONTAINER10GM/100MLinjectable · injectionFRESENIUS KABI USAPrescription16 Jul 2018
DEXTROSE 50%500MG/MLinjectable · injectionINTL MEDICATION SYSPrescription26 Mar 2021
DEXTROSE 10% IN PLASTIC CONTAINER10GM/100MLinjectable · injectionB BRAUNDiscontinued21 Feb 1978

19 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
10% DEXTROSE INJECTION USP01924427100 MG / MLSOLUTION · INTRAVENOUSB. BRAUN MEDICAL INC
10% DEXTROSE INJECTION, USP0006036410 G / 100 MLSOLUTION · INTRAVENOUSBAXTER CORPORATION
5% DEXTROSE INJECTION0240353650 MG / MLSOLUTION · INTRAVENOUSFRESENIUS KABI CANADA LTD
5% DEXTROSE INJECTION USP0192428150 MG / MLSOLUTION · INTRAVENOUSB. BRAUN MEDICAL INC
5% DEXTROSE INJECTION, USP000603485 G / 100 MLSOLUTION · INTRAVENOUSBAXTER CORPORATION
70% DEXTROSE INJECTION USP0201487470 G / 100 MLSOLUTION · INTRAVENOUSBAXTER CORPORATION
DEXTROSE INJECTION0251713250 % / W/VSOLUTION · INTRAVENOUSOMEGA LABORATORIES LIMITED
DEXTROSE INJECTION USP0003791550 MG / MLSOLUTION · INTRAVENOUSICU MEDICAL CANADA INC
DEXTROSE INJECTION USP02468514500 MG / MLSOLUTION · INTRAVENOUSPFIZER CANADA ULC

Safety signals and safety-related labeling changes

All safety entries for dextrose →

Combinations containing Dextrose

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.